Immuneel
PrivateLast Round
Grant
Jun 10, 2025
Est. Valuation
$71M
Total Funding Raised
$42.15M
Momentum Score
25 /100
Company Overview
Immuneel is a clinical-stage biotechnology company based in Bengaluru, India, focused on making advanced cell and gene therapies accessible and affordable. Co-founded in 2018 by Kiran Mazumdar-Shaw, Dr. Siddhartha Mukherjee, and Dr. Kush Parmar, the company is a pioneer of Chimeric Antigen Receptor T-cell (CAR-T) therapy in India. Immuneel is actively conducting clinical trials, including its 'IMAGINE' Phase II trial for a CAR-T therapy targeting B-cell malignancies. The company has raised significant venture funding to advance its development pipeline, scale its manufacturing capabilities, and commercialize its treatments for cancer patients in India and beyond.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immuneel Comps
Public and private peers based on sector, stage, and business model.
Immuneel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 10, 2025 | ||||
| Series A Extension | Jul 9, 2024 | ||||
| Series A | Jun 21, 2022 | ||||
| Seed | Jan 8, 2020 |
Key People
Founding team and executive leadership
Immuneel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series A, Seed |
| Eight Roads Ventures | Series A, Seed |
| True North | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Partnered with healthcare lending marketplace CarePal Money.
- Jan 8, 2026
Partnered with Impact Guru, a healthcare crowdfunding platform.
Immuneel Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immuneel's valuation, stock price, and market status.
